If you're living with diabetes, you're probably aware of its effects on your blood sugar and general health. But did you know ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Diabetes is a chronic condition where the body cannot regulate blood sugar levels. This occurs when the body either doesn't ...

Researchers have identified in a new study that tight blood sugar control within a period of one year did not have a notable ...

An initial trial suggests lamivudine, an inexpensive oral drug for treating HIV, can improve vision in patients with diabetic ...

Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only ...

At ARVO 2025, in Salt Lake City, Utah, Emma Lessieru, MD, PhD, talked about her poster on retina extracellular vesicles, and the role that they play on diabetic retinopathy.

One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months ...

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

Genentech's ranibizumab injection (Susvimo) has received FDA approval for the treatment of diabetic retinopathy. The ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...